# ENSTILAR
> **NDA207589** · New Drug Application · Sponsor: LEO PHARMA AS · Approved 2015-10-16
## Drug
- **FDA Application Number:** NDA207589
- **Application type:** New Drug Application
- **Brand name:** ENSTILAR
- **Generic name:** CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
- **Active ingredients:** BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE
- **Dosage form:** AEROSOL, FOAM
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** LEO PHARMA AS
- **Manufacturer:** LEO Pharma Inc.
- **First approval:** 2015-10-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207589)
---
*MORVS · CC0 1.0*